Experimental Drug RCM-1 May Have Therapeutic Potential to Block Inflammation and Mucus-Producing Cells Expansion
Asthma, News
Researchers from Cincinnati Children’s Hospital Medical Center found a new compound with therapeutic potential to block a protein called FOXM1, which is responsible for pro-inflammatory and hyper-mucous activity in asthma ... Read more